SynthesisBreast cancer research and treatment2017

Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.

Florence R Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.